Author | Ariela Katz | OncLive

Author | Ariela Katz


An Explorer's Mentality Leads to Novel Treatments in Prostate and Bladder Cancer

December 10, 2018

Although he held a longtime fascination with space exploration to the moon and Mars, Daniel P. Petrylak, MD, took a different path and broke new ground in another frontier: genitourinary oncology.

San Diego Urology Group Enjoys Growth in a Tough Market

November 30, 2018

Genesis Healthcare Partners, the region’s largest independent urology practice, is challenged by regulatory changes and the dominance of the regional managed care market, which has huge control of patient flow and payment structures.

Triplet Therapy With Novel PD-1 Inhibitor Holds Promise in Melanoma

November 28, 2018

The addition of a novel PD-1 inhibitor to a combination of BRAF inhibitor dabrafenib (Tafinlar) and MEK inhibitor trametinib (Mekinist) is being tested to determine whether the triplet is safe and effective for patients with metastatic or unresectable melanoma.

Novel Oral Paclitaxel Formulation Aims to Overcome Drawbacks of IV Version

November 12, 2018

Investigators are assessing whether Oraxol, an oral formulation of paclitaxel, will be safer and more efficacious than the widely used chemotherapy drug administered by traditional intravenous infusion.